Challenges Facing Families at the End of Life in Three Settings.

J Soc Work End Life Palliat Care

KL2 Scholar, University of Wisconsin-Madison, School of Nursing.

Published: July 2009

This study examined the challenges faced by family members at the end of life in different care settings and how those challenges compare across settings. A total of 30 participants, who had a family member die in inpatient hospice, a skilled nursing facility or a community support program were interviewed. Semi-structured interviews were recorded and transcribed. Text was coded using qualitative thematic analysis. Themes were determined by consensus. Twelve challenges were identified across care sites. Two themes emerged in all three settings: bearing witness and the experience of loss. The study findings contribute to our knowledge of family perceptions of care in different settings and raises awareness of the need for further research describing the experiences at the end of life in different settings and the importance of creating and testing interventions for both setting specific needs and universal issues.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886299PMC
http://dx.doi.org/10.1080/15524250903555080DOI Listing

Publication Analysis

Top Keywords

three settings
8
care settings
8
settings
6
challenges
4
challenges facing
4
facing families
4
families life
4
life three
4
settings study
4
study examined
4

Similar Publications

Accurate classification of logos is a challenging task in image recognition due to variations in logo size, orientation, and background complexity. Deep learning models, such as VGG16, have demonstrated promising results in handling such tasks. However, their performance is highly dependent on optimal hyperparameter settings, whose fine-tuning is both labor-intensive and time-consuming.

View Article and Find Full Text PDF

A real-world pharmacovigilance analysis of potential ototoxicity associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS).

Sci Rep

December 2024

Department of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

Sacubitril/valsartan, a first-in-class angiotensin receptor neprilysin inhibitor, is widely used to treat heart failure. Despite its efficacy, sacubitril/valsartan inevitably causes adverse events such as hypotension, renal dysfunction, hyperkalemia, and angioedema. Sacubitril/valsartan-associated ototoxicity is often underreported in clinical studies and real-world settings.

View Article and Find Full Text PDF

The transition from secondary school to college or university is a well-known and well-studied risk period for weight and/or fat gain and not meeting the dietary recommendations. Higher education acts as a promising setting to implement nutrition interventions. An important condition for intervention success is that interventions are implemented as intended by the protocol and integrated in the institutional policy.

View Article and Find Full Text PDF

Proper exposure settings are crucial for modern machine vision cameras to accurately convert light into clear images. However, traditional auto-exposure solutions are vulnerable to illumination changes, splitting the continuous acquisition of unsaturated images, which significantly degrades the overall performance of underlying intelligent systems. Here we present the neuromorphic exposure control (NEC) system.

View Article and Find Full Text PDF

Molecular epidemiology of invasive group B Streptococcus in South Africa, 2019-2020.

J Infect Dis

December 2024

Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.

Background: Group B Streptococcus (GBS) is a leading cause of neonatal meningitis and sepsis and an important cause of disease in adults. Capsular polysaccharide and protein-based GBS vaccines are currently under development.

Methods: Through national laboratory-based surveillance, invasive GBS isolates were collected from patients of all ages between 2019 and 2020.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!